SurModics SRDX 深 滬
交易中 09-19 12:51:22 美东时间
39.48
+0.180
+0.46%
華盛通- 最 高39.54
- 今 開39.54
- 成交量 1.89万股
- 最 低 39.19
- 昨 收 39.30
- 總市值 5.58亿
- 52周最高 42.44
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 25.17
- 委 比 -24.14%
- 總股本 1413.40万
- 歷史最高 82.35
- 量 比 0.13
- 振 幅 0.89%
- 歷史最低 8.73
- 每 手 1
- 風險率 4.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Surmodics merger deal draws FTC second request
Medical device maker Surmodics (NASDAQ:SRDX) announced Tuesday that the Federal Trade Commission (FTC) has requested more information on its pending merger agreement with the affiliates of private equ...
08-13 19:00
Needham Reiterates Hold on Surmodics
Needham analyst Mike Matson reiterates Surmodics (NASDAQ:SRDX) with a Hold.
08-06 01:51
Surmodics beats top-line and bottom-line estimates; suspends annual guidance
Surmodics press release (NASDAQ:SRDX): Q3 Non-GAAP EPS of -$0.27 beats by $0.06. Revenue of $30.3M (-42.3% Y/Y) beats by $0.29M. Adjusted EBITDA was $1.6M, compared to Adjusted EBITDA of $24.6M in the...
07-31 20:53
Surmodics secures thrombectomy products agreement with Premier
Surmodics (NASDAQ:SRDX) awarded a group purchasing agreement for thrombectomy products with Premier, effective June 1, 2024. The new agreement allows Premier members, at their discretion, to take adva...
06-10 20:08
Assessing Surmodics: Insights From 5 Financial Analysts
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three month...
05-31 01:01
Barrington Research Downgrades Surmodics to Market Perform
Barrington Research analyst Michael Petusky downgrades Surmodics (NASDAQ:SRDX) from Outperform to Market Perform.
05-30 22:06
美股牛股 | 业绩利好驱动！Chewy、路特斯隔夜皆现双位数涨幅
宠物电商平台Chewy隔夜涨27.1%，业绩超预期并宣布股票回购计划；高端豪华电动汽车制造商路特斯隔夜涨25.5%，一季度营收同比暴增811%>>
05-30 15:17
SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SRDX, MRO, ATRI, CALT
NEW YORK, May 29, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
05-30 03:27
Sidoti & Co. Downgrades Surmodics to Neutral, Announces $43 Price Target
Sidoti & Co. analyst James Sidoti downgrades Surmodics (NASDAQ:SRDX) from B...
05-30 00:41
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
Surmodics will be acquired by GTCR for $43.00 per share, totaling $627 million. This 41.1% premium reflects Surmodics' advancements in surface modification for medical devices and IVD technologies.
05-29 22:48
